Signup Crypto ETF Stocks News

Dell Upgraded, Costco Downgraded: Updated Rankings on Top Blue-Chip Stocks

Louis Navellier has revised his Stock Grader recommendations for 104 blue-chip stocks based on institutional buying pressure and fundamental health. Dell Technologies (DELL) was upgraded from Strong to Very Strong, while Costco Wholesale (COST) was downgraded from Neutral to Weak. The article provides detailed lists of upgrades and downgrades across various rating categories.

Source: InvestorPlace
June 02, 2026 | 16:00:29
Category: General

Invesco NASDAQ 100 ETF Up 40% in 12 Months: June Rebalance Brings New Rules for QQQM

The Invesco NASDAQ 100 ETF (QQQM) has outperformed its peers with a 40% return in 12 months, driven by AI spending. The fund, a lower-cost alternative to QQQ, will undergo its first quarterly rebalance under new Nasdaq-100 rules on June 22, 2026, which will affect constituent eligibility and weighting. Investors are weighing the benefits of its concentrated tech portfolio against potential risks like sector rotation or valuation corrections.

Source: Tech Times
June 02, 2026 | 16:04:08
Category: General

Lam Research (NASDAQ: LRCX) SVP sells 7,659 shares under 10b5-1 plan

Lam Research Senior Vice President, Neil J. Fernandes, sold 7,659 shares of common stock at $309.60 per share under a pre-arranged Rule 10b5-1 trading plan. This transaction, valued at approximately $2.37 million, is considered a routine liquidity event given that Fernandes still retains a substantial holding of 58,470 direct shares and 1,015.395 indirect shares. The sale, adopted on November 17, 2025, reflects a planned rather than opportunistic disposition of stock.

Source: Stock Titan
June 02, 2026 | 16:05:14
Category: General

BA Stock Outperforms Industry in 6 Months: Should You Stay Invested?

Boeing (BA) shares have outperformed the aerospace-defense industry over the past six months, rising 9.1% while the industry declined 1%. This outperformance is driven by strong commercial and defense order activity, substantial backlogs, and a promising outlook for the aviation services market. Despite these positives, Boeing faces challenges including high debt levels and poor return on invested capital, suggesting that new investors might consider waiting for a better entry point, while existing investors may want to retain their holdings.

Source: The Globe and Mail
June 02, 2026 | 16:07:09
Category: General

The Only Public Space Stock Even Elon Musk Can’t Dismiss

Rocket Lab (NASDAQ:RKLB) is highlighted as the only publicly tradable pure-play space company that even SpaceX acknowledges as a competitor. The article discusses Rocket Lab's strong backlog, the upcoming Neutron rocket launch for medium-lift payloads, and significant defense contracts, positioning it as a potential "second SpaceX-shaped business." Despite its potential, the company faces risks including a net loss, high valuation (122 times sales), and a slipping Neutron launch schedule.

Source: 24/7 Wall St.
June 02, 2026 | 16:09:30
Category: General

SDST: All but one proposal passed, with final results to be disclosed in a Form 8-K

Stardust Power Inc. (SDST) held its AGM 2026, where all but one of the five key proposals were approved by stockholders. The meeting included board introductions, a Q&A session, and the final voting outcomes are pending disclosure in a Form 8-K.

Source: TradingView
June 02, 2026 | 16:10:20
Category: General

Scienture (SCNX) Secures Patent for Rezenopy Nasal Spray

Scienture Holdings Inc. (SCNX) has been awarded U.S. Patent No. 12,622,903 B2 for its Rezenopy Nasal Spray, effective until 2041, which solidifies its position in the healthcare market for CNS treatments. Although this patent enhances commercial viability, the company faces financial challenges, as indicated by declining revenue and a low profitability score, suggesting a mixed outlook for investors. The patented product will be manufactured by Summit Biosciences, allowing Scienture to focus on sales and marketing.

Source: GuruFocus
June 02, 2026 | 16:10:50
Category: General

Shareholder Alert: Ademi LLP investigates whether Rallybio Corporation is obtaining a Fair Price for Public Shareholders

Ademi LLP is investigating Rallybio (Nasdaq: RLY) regarding its recently announced transaction with Avenzo Therapeutics, citing potential breaches of fiduciary duty and other legal violations. Rallybio equityholders are expected to own only 2.8% of the combined company, while Avenzo equityholders will own 97.2%. The firm is examining whether Rallybio's board of directors is fulfilling its fiduciary duties to all shareholders, especially given that Rallybio insiders are set to receive substantial benefits and the transaction agreement imposes a significant penalty on competing bids.

Source: PR Newswire
June 02, 2026 | 16:14:37
Category: General

Jack Henry (JKHY) Enhances Payment Services Through Aeropay Inte

Jack Henry (JKHY) has integrated its Payments Orchestrator into Aeropay's platform, enhancing Aeropay's instant payment and pay-by-bank features. This collaboration aims to improve efficiency and resilience in payment processing, benefiting both companies in the digital economy. Jack Henry's strong GF Score™ of 86/100 and robust financial metrics suggest solid growth potential, despite its current P/E ratio of 19.1 being near its 10-year low.

Source: GuruFocus
June 02, 2026 | 16:15:09
Category: General

Valero Energy Corp stock (US91913Y1001): Q2 2026 earnings date set as shares hover near 52-week high

Valero Energy Corp (NYSE: VLO) has scheduled its Q2 2026 earnings release for July 30, 2026, with a conference call following at 10:00 a.m. Eastern Time. The stock is currently trading near its 52-week high, with recent fund flows indicating strong institutional interest. The upcoming earnings report is expected to be a significant focal point for investors, especially given the company's previous quarter's strong performance, exceeding analyst expectations in EPS and revenue.

Source: Ad Hoc News
June 02, 2026 | 16:16:58
Category: General

© Natavest 2025 - 2026